Healthcare provider profile · identity verified

Thu Quynh Pham

Family Practice · CHICAGO, IL · NPI 1093126922

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	357	149
Amlodipine Besylate	Amlodipine Besylate	256	105
Lisinopril	Lisinopril	208	89
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	159	42
Levothyroxine Sodium	Levothyroxine Sodium	153	57
Losartan Potassium	Losartan Potassium	147	68
Fluticasone Propionate	Fluticasone Propionate	145	74
Atenolol	Atenolol	117	41
Metformin Hcl Er	Metformin Hcl	112	45
Hydrochlorothiazide	Hydrochlorothiazide	111	49
Famotidine	Famotidine	105	49
Albuterol Sulfate Hfa	Albuterol Sulfate	103	71
Gabapentin	Gabapentin	81	35
Metoprolol Succinate	Metoprolol Succinate	81	31
Allopurinol	Allopurinol	80	30
Tizanidine Hcl	Tizanidine Hcl	79	54
Montelukast Sodium	Montelukast Sodium	71	34
Simvastatin	Simvastatin	68	26
Furosemide	Furosemide	65	28
Alendronate Sodium	Alendronate Sodium	64	24
Naproxen	Naproxen	63	44
Tamsulosin Hcl	Tamsulosin Hcl	63	25
Metoprolol Tartrate	Metoprolol Tartrate	61	27
Lisinopril-Hydrochlorothiazide	Lisinopril/Hydrochlorothiazide	58	25
Glipizide	Glipizide	56	19
Metformin Hcl	Metformin Hcl	56	26
Meloxicam	Meloxicam	54	17
Omeprazole	Omeprazole	54	26
Pantoprazole Sodium	Pantoprazole Sodium	54	30
Ibuprofen	Ibuprofen	52	35
Alvesco	Ciclesonide	50	34
Hydrocortisone	Hydrocortisone	44	12
Triamcinolone Acetonide	Triamcinolone Acetonide	44	22
Clopidogrel	Clopidogrel Bisulfate	40	17
Hydralazine Hcl	Hydralazine Hcl	39	16
Spiriva Respimat	Tiotropium Bromide	37	16
Lidocaine	Lidocaine	36	22
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	36	14
Terazosin Hcl	Terazosin Hcl	35	11
Lovastatin	Lovastatin	34	14
Sertraline Hcl	Sertraline Hcl	34	16
Prednisone	Prednisone	33	26
Trazodone Hcl	Trazodone Hcl	32	19
Humulin N	Insulin Nph Human Isophane	31	12
Breyna	Budesonide/Formoterol Fumarate	29	16
Jardiance	Empagliflozin	28	11
Colchicine	Colchicine	27	14
Potassium Chloride	Potassium Chloride	26	17
Rosuvastatin Calcium	Rosuvastatin Calcium	25	suppressed
Escitalopram Oxalate	Escitalopram Oxalate	24	11
Fluoxetine Hcl	Fluoxetine Hcl	24	12
Ipratropium Bromide	Ipratropium Bromide	24	suppressed
Doxycycline Monohydrate	Doxycycline Monohydrate	23	18
Ropinirole Hcl	Ropinirole Hcl	21	suppressed
Nortriptyline Hcl	Nortriptyline Hcl	19	suppressed
Pioglitazone Hcl	Pioglitazone Hcl	19	suppressed
Acyclovir	Acyclovir	18	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	17	16
Mirtazapine	Mirtazapine	17	suppressed
Pradaxa	Dabigatran Etexilate Mesylate	17	suppressed
Bupropion Xl	Bupropion Hcl	16	suppressed
Clonazepam	Clonazepam	16	suppressed
Spironolactone	Spironolactone	16	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	16	suppressed
Zolpidem Tartrate	Zolpidem Tartrate	16	suppressed
Ibandronate Sodium	Ibandronate Sodium	14	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	14	suppressed
Temazepam	Temazepam	14	suppressed
Topiramate	Topiramate	14	suppressed
Veo Insulin Syringe	Syringe-Needle,insulin,0.5 Ml	14	suppressed
Acetaminophen-Codeine	Acetaminophen With Codeine	13	suppressed
Carvedilol	Carvedilol	13	suppressed
Cefadroxil	Cefadroxil	13	suppressed
Diltiazem 24hr Er (Cd)	Diltiazem Hcl	13	suppressed
Finasteride	Finasteride	13	suppressed
Ondansetron Hcl	Ondansetron Hcl	13	11
Clonidine Hcl	Clonidine Hcl	12	suppressed
Duloxetine Hcl	Duloxetine Hcl	12	suppressed
Glipizide Er	Glipizide	12	suppressed
Lactulose	Lactulose	12	suppressed
Lorazepam	Lorazepam	12	suppressed
Sucralfate	Sucralfate	12	suppressed
Azelastine Hcl	Azelastine Hcl	11	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	11	11
Nystatin	Nystatin	11	suppressed
Pregabalin	Pregabalin	11	suppressed
Propranolol Hcl	Propranolol Hcl	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error